Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments

por Jemaa, S., Paulson, J. N., Hutchings, M., Kostakoglu, L., Trotman, J., Tracy, S., de Crespigny, A., Carano, R. A. D., El-Galaly, T. C., Nielsen, T. G., Bengtsson, T.
Publicado 2022

RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury

por Newton, K, Dugger, D L, Maltzman, A, Greve, J M, Hedehus, M, Martin-McNulty, B, Carano, R A D, Cao, T C, van Bruggen, N, Bernstein, L, Lee, W P, Wu, X, DeVoss, J, Zhang, J, Jeet, S, Peng, I, McKenzie, B S, Roose-Girma, M, Caplazi, P, Diehl, L, Webster, J D, Vucic, D
Publicado 2016